Lannett CDMO

About Lannett CDMO

Founded in 1942, Lannett Company, Inc., is a long-established manufacturer of unique pharmaceutical indications with over 100 product families currently in distribution. Our deep industry knowledge of end-to-end solutions can be customized to our clients’ needs, keeping people and patients at the center of what we do.

From formulation development to commercial supply, our dedicated staff strive in excellence to ensure the desired product quality is met, suitable process performance is achieved, appropriate process controls are in-place, improvement opportunities are identified and product body of knowledge is continually expanded.

Our facilities sit on ~30 acres and include production space of ~224k sq.ft. and 204k sq.ft. of warehousing and distribution space. This translates to a manufacturing capacity of ~3.5B Oral solid doses and ~2.0M liters of liquids per year, and capabilities to produce the pharmaceutical product that you need. We offer expertise in the development of oral solid dosage forms for your most challenging small molecules including highly potent, poorly soluble, and DEA controlled substances. 

Lannett’s capabilities include but are not limited to:

  • IR and ER (tablets & capsules)
  • OROS technology (laser drill)
  • Pellets, oral solutions and suspensions
  • Bottles & Blister Packaging
  • Warehousing & Distribution
  • DEA Schedule I-V
  • Freezer & Refrigeration
  • Solvents

Certifications
  • US
  • 2023
    On CPHI since
  • 3
    Certificates
  • 250 - 499
    Employees
Company types
CMO/CDMO
Primary activities
Contract Manufacturer
Contact info
  • 1150 Northbrook Drive, Suite 155, 19053, Trevose, Pennsylvania, United States
Meet us at

CPHI North America 2024

Pennsylvania Convention Center, Philadelphia
07 May 2024 - 09 May 2024

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Lannett CDMO (1)

  • Manufacturing

    Product Manufacturing

    We specialize in oral solid dose, liquids and packaging